Gregory Richmond

Vice President and Head of Technology at Enumera Molecular | San Diego, California, United States

About Gregory Richmond

Gregory Richmond currently serves as the Vice President and Head of Technology at Enumera Molecular, where he spearheads the development of cutting-edge technologies aimed at revolutionizing the field of molecular diagnostics. With a robust background as a Ph.D. scientist, Gregory brings a wealth of expertise in reagent development and advanced DNA/RNA detection and analysis techniques. His leadership is pivotal in driving key projects, particularly the innovative single molecule counting and detection platform tailored for liquid biopsy applications. This platform represents a significant advancement in the ability to detect and analyze biomarkers at unprecedented sensitivity, offering new hope for early disease diagnosis, especially in conditions that currently lack effective diagnostic solutions.

Under Gregory's guidance, Enumera Molecular is positioned at the forefront of the molecular diagnostics landscape, leveraging state-of-the-art technologies such as next-generation sequencing (NGS) and mass spectrometry. His extensive experience in assay development and research and development (R&D) ensures that the company remains agile and responsive to the rapidly evolving needs of the healthcare sector. Gregory's commitment to technology integration and sample preparation methodologies enhances the reliability and efficiency of diagnostic processes, ultimately contributing to improved patient outcomes. His passion for advancing our understanding of human disease drives his team's efforts to create innovative solutions that not only enhance diagnostic capabilities but also pave the way for personalized medicine. As a thought leader in the industry, Gregory Richmond continues to inspire and lead initiatives that bridge the gap between scientific discovery and clinical application.

Gregory Richmond Work